Usefulness of positron emission tomography-computed tomography in pre-operative evaluation of intra-thoracic esophageal cancer

Thoracic Cancer

Volumn 6, Issue 6, 2015, Pages 687-694

  Kim, Jae Jun ^a   Park, Jae Kil ^b   Moon, Seok Whan ^c  

^a Uijeongbu St Mary's Hospital   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Esophageal cancer; PET CT; Regional lymph node

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRA THORACIC ESOPHAGEAL CANCER; INTRATHORACIC ESOPHAGEAL CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PET-CT SCANNER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; THORAX CANCER; THORAX TUMOR; VERY ELDERLY;

EID: 84945477489     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/1759-7714.12237     Document Type: Article

References (16)

1. Bella AJ, Zhang YR, Fan W etal. Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis for thoracic esophageal squamous cell carcinoma. Chin J Cancer 2014; 33: 211-217.
2. Brown C, Howes B, Jamieson GG etal. Accuracy of PET-CT in predicting survival in patients with esophageal cancer. World J Surg 2012; 36: 1089-1095.
3. Shi W, Wang W, Wang J, Cheng H, Huo X. Meta-analysis of 18FDG PET-CT for nodal staging in patients with esophageal cancer. Surg Oncol 2013; 22: 112-116.
4. You JJ, Wong RK, Darling G, Gulenchyn K, Urbain JL, Evans WK. Clinical utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the staging of patients with potentially resectable esophageal cancer. J Thorac Oncol 2013; 8: 1563-1569.
5. Blom RL, Steenbakkers IR, Lammering G etal. PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 2013; 40: 1500-1506.
6. Manabe O, Hattori N, Hirata K etal. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer. J Nucl Med 2013; 54: 670-676.
7. Huang TC, Wang YC. Deformation effect on SUVmax changes in thoracic tumors using 4-D PET/CT scan. PLoS ONE 2013; 8 (3): e58886.
8. 18F-fluorodeoxyglucose uptake in primary lesions and clinicopathological characteristics of esophageal squamous cell carcinoma patients. Exp Ther Med 2013; 5: 170-174.
9. 18F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma. Surg Today 2014; 44: 1258-1265.
10. Kumar P, Damle NA, Bal C. Role of F18-FDG PET/CT in the staging and restaging of esophageal cancer: A comparison with CECT. Indian J Surg Oncol 2011; 2: 343-350.
11. Crabtree TD, Kosinski AS, Puri V etal. Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer:A review of the Society of Thoracic Surgeons database. Ann Thorac Surg 2013; 96: 382-390.
12. Metser U, Rashidi F, Moshonov H etal. (18)F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer. Ann Nucl Med 2014; 28: 295-303.
13. Miyazaki T, Sohda M, Higuchi T etal. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer. Anticancer Res 2014; 34: 283-287.
14. Terán MD, Brock MV. Staging lymph node metastases from lung cancer in the mediastinum. J Thorac Dis 2014; 6: 230-236.
15. Tachibana M, Kinugasa S, Hirahara N, Yoshimura H. Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma. Eur J Cardiothorac Surg 2008; 34: 427-431.
16. Torrance AD, Almond LM, Fry J, Wadley MS, Lyburn ID. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer? Surgeon 2015; 13: 19-33.